Immunoreactive Akt, PI3-K and ERK protein kinase expression in ischemic rat brain

Neuroscience Letters

Volumn 274, Issue 1, 1999, Pages 45-48

  Kitagawa, Hisashi ^a,b   Warita, Hitoshi ^a   Sasaki, Chihoko ^a   Ri Zhang, Wen ^a   Sakai, Kenichi ^a   Shiro, Yoshihoko ^a   Mitsumoto, Yasuhide ^b   Mori, Toyoki ^b   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Akt 1; ERK 1; Immunoreactivity; Ischemia; MCAO; PI3 K; Rats

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; HISTOLOGY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BRAIN ISCHEMIA; CAUDATE NUCLEUS; CEREBRAL CORTEX; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR;

EID: 0032886308     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00676-X     Document Type: Article

References (21)

1. Abe K., Hayashi T. Expression of the glial cell line-derived neurotrophic factor gene in rat brain after transient MCA occlusion. Brain Res. 776:1997;230-234.
2. Anderson C.N.G., Tolkovsky A.M. A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent JNK-independent induction of apoptosis by cytosine arabinoside. J. Neurosci. 19:1999;664-673.
3. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., Yancopoulos G.D. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 65:1991;663-675.
4. Charriaut-Marlangue C., Margaill I., Represa A., Popovici T., Plotkine M., Ben-Ari Y. Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J. Cereb. Blood Flow Metab. 16:1996;186-194.
5. Crowder R.J., Freeman R.S. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neurosci. 18:1998;2933-2943.
6. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
7. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:1997;661-665.
8. Harada K., Maekawa T., Abu Shama K.M., Yamashima T., Yoshida K. Translocation and down-regulation of protein kinase C-alpha -beta and -gamma isoforms during ischemia-reperfusion in rat brain. J. Neurochem. 72:1999;2556-2564.
9. Hayashi T., Abe K., Sakurai M., Itoyama Y. Inductions of hepatocyte growth factor and its activator in rat brain with permanent middle cerebral artery occlusion. Brain Res. 799:1998;311-316.
10. Hayashi T., Warita H., Abe K., Itoyama Y. Expression of cyclin-dependent kinase 5 and its activator p35 in rat brain after middle cerebral artery occlusion. Neurosci. Lett. 265:1999;37-40.
11. Hossmann K.A. Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 36:1994;557-565.
12. Hu B.R., Wieloch T. Tyrosine phosphorylation and activation of mitogen-activated protein kinase in the rat brain following transient cerebral ischemia. J. Neurochem. 62:1994;1357-1367.
13. Kitagawa H., Hayashi T., Mitsumoto Y., Koga N., Itoyama Y., Abe K. Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke. 29:1998;1417-1422.
14. Kogure K., Kato H. Altered gene expression in cerebral ischemia. Stroke. 24:1993;2121-2127.
15. Mattson M.P., Scheff S.W. Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neurotrauma. 11:1994;3-33.
16. Philpott K.L., McCarthy M.J., Klippel A., Rubin L.L. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J. Cell Biol. 139:1997;809-815.
17. Schäbitz W.-R., Schwab S., Spranger M., Hacke W. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cereb. Blood Flow Metab. 17:1997;500-506.
18. Tanaka R., Miyasaka Y., Yada K., Ohwada T., Kameya T. Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model. Stroke. 26:1995;2154-2159.
19. Villalba M., Bockaert J., Journot L. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J. Neurosci. 17:1997;83-90.
20. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK andJNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
21. Yan C.Y.I., Greene L.A. Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway. J. Neurosci. 18:1998;4042-4049.